Highlights from Zacks Analyst Blog: Microsoft, NVIDIA, Medtronic, The Progressive and Vertex Pharma


For immediate release

Chicago, IL – December 7, 2021 – Zacks.com announces the list of stocks featured on the Analysts Blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Recent stocks featured in the blog include: Microsoft Corporation MSFT, NVIDIA Corporation NVDA, Medtronic plc MDT, The Progressive Corporation PGR, and Vertex Pharmaceuticals Inc. VRTX.

Here are highlights from Monday’s analyst blog:

Best Stock Reports for Microsoft, NVIDIA and Medtronic

Zacks Research Daily features the best research results from our team of analysts. Today’s Research Daily features new research reports on 16 major stocks, including Microsoft, NVIDIA, and Medtronic. These research reports were handpicked from over 70 reports released today by our team of analysts.

You can see all today’s research reports here >>>

Actions of Microsoft outperformed the S&P 500 over the past year (+ 52% vs. + 25%). Zacks analyst believes that Microsoft has benefited greatly from the strength of its Azure cloud platform amid accelerating global digital transformation.

The growth in the number of Microsoft Teams users has also increased thanks to the continued trend of remote working as well as the widespread adoption of the hybrid / flexible working model. Strong adoption of new Xbox consoles improves performance in gaming segment. MSFT is also witnessing a growth in the user base of its various applications, including the Microsoft 365 suite, Dynamics and Power Platform.

(You can read the full Microsoft research report here >>>)

NVIDIA stocks gained + 135.3% in the cumulative period of the year against the industry gain of + 68.7% of Zacks General Semiconductor. Zacks analyst believes NVIDIA has benefited from the coronavirus-induced wave of work and home learning, as well as the strong growth in GeForce graphics processing units for desktops and laptops.

A sharp increase in Hyperscale demand remains a tailwind for the company’s data center business. The expansion of NVIDIA GeForce NOW is expected to boost the user base. Another positive development is the strong adoption of AI-powered smart cockpit infotainment solutions. The collaboration with Mercedes-Benz should also strengthen NVIDIA’s presence in the field of autonomous vehicles.

(You can read the full research report on NVIDIA here >>>)

Actions of Medtronic lost -13% in the past six months versus Zacks’ medical products industry’s -7.3% loss; however, things appear to be improving for the company. Zacks analyst believes that all of MDT’s major business groups have reported consistent gains, highlighting sustainability across groups and regions.

Medtronic second quarter FY2022 earnings exceeded Zacks’ consensus estimate and delivered organic growth in the Cardiovascular, Neuroscience and Diabetes segments. Gross and operating margins for the quarter improved year over year. MDT, however, continues to be under pressure from labor shortages in the healthcare system as well as the ongoing pandemic.

(You can read the full research report on Medtronic here >>>)

Other noteworthy reports we present today include The Progressive and Vertex Pharma.

Media contact

Zacks investment research

800-767-3771 ext 9339

[email protected]


Past performance is no guarantee of future results. The potential for loss is inherent in any investment. This material is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether an investment is suitable for a particular investor. It should not be assumed that any investment in any identified and described securities, companies, sectors or markets was or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or securities asset management activities. These returns come from hypothetical portfolios made up of stocks with a Zacks rank = 1 that have been rebalanced monthly without any transaction costs. These are not the returns of actual equity portfolios. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for more information on the performance numbers displayed in this press release.

5 actions in the process of doubling

Each was selected by a Zacks expert as the # 1 favorite stock to earn + 100% or more in 2021. Previous recommendations climbed + 143.0%, + 175.9%, + 498.3% and + 673.0%.

Most of the stock in this report is flying under Wall Street’s radar, which provides a great opportunity to get into the ground floor.

Today, discover these 5 potential circuits >>

Click to get this free report

Microsoft Corporation (MSFT): Free Stock Analysis Report

Medtronic PLC (MDT): Free Stock Analysis Report

NVIDIA Corporation (NVDA): Free Inventory Analysis Report

Vertex Pharmaceuticals Incorporated (VRTX): Free Stock Analysis Report

The Progressive Corporation (PGR): Free share analysis report

To read this article on Zacks.com, click here.

Zacks investment research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


Comments are closed.